These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 22006548

  • 1. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer.
    Sun S, Jiang Y, Zhang G, Song H, Zhang X, Zhang Y, Liang X, Sun Q, Pang D.
    J Surg Oncol; 2012 Jun 15; 105(8):773-9. PubMed ID: 22006548
    [Abstract] [Full Text] [Related]

  • 2. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ, Seo AN, Park SY, Kim JY, Park JY, Yu JH, Ahn JH, Gong G.
    Ann Surg Oncol; 2014 May 15; 21(5):1561-8. PubMed ID: 24385208
    [Abstract] [Full Text] [Related]

  • 3. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietiläinen T, Böhm J, Eskelinen M, Kosma VM.
    Clin Cancer Res; 2002 Nov 15; 8(11):3487-95. PubMed ID: 12429639
    [Abstract] [Full Text] [Related]

  • 4. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B, Liu FF, Ma YJ, Gu F.
    Zhonghua Zhong Liu Za Zhi; 2013 Dec 15; 35(12):904-9. PubMed ID: 24506959
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 15; 30(12):917-20. PubMed ID: 19173993
    [Abstract] [Full Text] [Related]

  • 6. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M.
    Ann Acad Med Stetin; 2009 Dec 15; 55(1):22-30. PubMed ID: 20349588
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
    Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H.
    Breast Cancer Res Treat; 2008 Aug 15; 110(3):465-75. PubMed ID: 17805961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB, Peng WQ, Yi ZJ, Zhu SL, Gan QH.
    Ai Zheng; 2007 Sep 15; 26(9):996-1000. PubMed ID: 17927860
    [Abstract] [Full Text] [Related]

  • 15. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015
    [Abstract] [Full Text] [Related]

  • 16. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.
    Tumour Biol; 2016 Oct 01; 37(10):13721-13731. PubMed ID: 27476168
    [Abstract] [Full Text] [Related]

  • 17. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY, Subramanian A, Mokbel K, Sharma AK.
    J Surg Oncol; 2011 Sep 01; 104(3):228-35. PubMed ID: 21480260
    [Abstract] [Full Text] [Related]

  • 18. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG, Voss MJ, Habashy HO, Zänker KS, Green AR, Ellis IO, Entschladen F.
    Breast Cancer Res Treat; 2011 Nov 01; 130(2):457-63. PubMed ID: 21298476
    [Abstract] [Full Text] [Related]

  • 19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 20. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
    Ray PS, Bagaria SP, Wang J, Shamonki JM, Ye X, Sim MS, Steen S, Qu Y, Cui X, Giuliano AE.
    Ann Surg Oncol; 2011 Dec 01; 18(13):3839-47. PubMed ID: 21424368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.